← Latest news 
Zydus Biologics Ahmedabad facility faces seven USFDA observations but data integrity stays clean
Entertainment
Published on 6 May 2026
Seven observations emerge, but officials flagged data integrity as fine
Zydus Lifesciences says its Zydus Biologics injectable plant in Ahmedabad was inspected by the USFDA from April 27 to May 5, 2026. The audit resulted in seven observations, though the company emphasized that there were no data integrity issues. Zydus is now in discussions with the USFDA to address the findings promptly and maintain compliance.
- USFDA inspected Zydus Biologics Ahmedabad between April 27 and May 5
- Seven observations were issued during the inspection
- No data integrity concerns were found, according to the company
- Zydus is working with USFDA to close observations quickly
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times